Polysomnography indexes are discordant with quality of life,symptoms,and reaction times in sleep apnea patients

Abstract

OBJECTIVE: We tested whether polysomnography (PSG) indexes were associated with sleepiness, quality of life, or reaction times at baseline and as outcome measures following surgical or sham treatment for patients with obstructive sleep apnea syndrome (OSAS).

STUDY DESIGN AND METHODS: Mild-moderate OSAS subjects were measured before and 8 weeks after surgical or sham treatment in this prospective longitudinal study. Measures included standard PSG indexes, sleepiness, quality of life, and reaction times. Associations were examined with Spearman correlations and multivariate linear regression.

RESULTS: Correlations between baseline PSG and non-PSG measures ranged from −0.22 to 0.25 (n, 87 subjects; mean correlation, 0.00 ± 0.11), with one positive association significant of 56 tested (arousal index and SF36 Mental Component Summary, r, 0.25; P = 0.03). Correlations between change in PSG and non-PSG measures ranged from −0.37 to 0.35 (n, 54 subjects; mean correlation, −0.05 ± 0.19), with no significant positive association of 56 tested. Regression analyses confirmed these results.

CONCLUSIONS: PSG indexes are not consistently associated with sleepiness, quality of life, or reaction time, both at baseline and as outcome measures in patients with mild-moderate OSAS. PSG indexes may not quantify some important aspects of OSAS disease burden or treatment outcome. Clinically important outcomes should be measured directly. EBM rating: A.

Get full access to this article

View all access options for this article.

References

1. Indications and standards for cardiopulmonary sleep studies. American Thoracic Society. Medical section of the American Lung Association. Am Rev Respir Dis 1989; 139: 559–68.

2. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine task force. Sleep 1999; 22: 667–89.

3. Peppard

Young

Palta

, Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378–84.

4. Nieto

Young

Lind

, Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 2000; 283: 1829–36.

5. Shepard

Jr. Hypertension, cardiac arrhythmias, myocardial infarction, and stroke in relation to obstructive sleep apnea. Clin Chest Med 1992;13:437–58.

6. He

Kryger

Zorick

, Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest 1988;94:9–14.

7. Weaver

Kapur

Yueh

Polysomnography vs self-reported measures in patients with sleep apnea. Arch Otolaryngol Head Neck Surg 2004; 130: 453–8.

8. Weaver

Patrick

Deyo

, Sleep study and quality of life correlation in sleep apnea (Abstract). Otolaryngol Head Neck Surg 2000;123:106.

9. Woodson

Steward

Weaver

, A randomized trial of temperature-controlled radiofrequency, continuous positive airway pressure, and placebo for obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg 2003;128:848–61.

10.

10. Rechtschaffen

Kales

A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service/Brain Research Institute, UCLA, 1968.

11.

11. EEG arousals: rules and examples. a preliminary report from the disorders atlas task force of the American Sleep Disorders Association. Sleep 1992; 15: 174–84.

12.

12. Weaver

Laizner

Evans

, An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep 1997;20:835–43.

13.

13. Piccirillo

Gates

White

, Obstructive sleep apnea treatment outcomes pilot study. Otolaryngol Head Neck Surg 1998;118:833–44.

14.

14. Ware

Jr Snow

Kosinski

, SF-36 health survey: manual and interpretation guide. Boston, MA: The Health Institute, New England Medical Center, 1997.

15.

15. Johns

MW.

Daytime sleepiness, snoring, and obstructive sleep apnea: the Epworth Sleepiness Scale. Chest 1993;103:30–6.

16.

16. Jewett

Dijk

Kronauer

, Dose-response relationship between sleep duration and human psychomotor vigilance and subjective alertness. Sleep 1999;22:171–9.

17.

17. Primer on correlation coefficients. Effective Clinical Practice 2001; 4: 139–40.

18.

18. Hulley

Cummings

SR.

Designing clinical research: an epidemiologic approach. Baltimore, MD: Williams & Wilkins; 1988. pp. 247.

19.

19. Stewart

Sicard

Piccirillo

, Severity staging in chronic sinusitis: are CT scan findings related to patient symptoms? Am J Rhinol 1999;13:161–7.

20.

20. Brand

Duiverman

Waalkens

, Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD study group. Thorax 1999; 54: 103–7.

21.

21. Wiklund

Comerford

Dimenas

The relationship between exercise tolerance and quality of life in angina pectoris. Clin Cardiol 1991;14:204–8.

22.

22. Walker-Engstrom

Wilhelmsson

Tegelberg

, Quality of life assessment of treatment with dental appliance or UPPP in patients with mild to moderate obstructive sleep apnoea: a prospective randomized 1-year follow-up study. J Sleep Res 2000;9:303–8.

23.

23. Weaver

EM.

Sleep apnea devices and sleep apnea surgery should be compared on effectiveness, not efficacy (letter). Chest 2003;123:961–2.